CNS Protein Therapeutics Revenue
Biotechnology Research • 
Sunnyvale, California, United States • 1-10 Employees
$
CNS Protein Therapeutics revenue & valuation
| Annual revenue | $256,665 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $821,328 |
| Total funding | No funding |
Key Contact at CNS Protein Therapeutics
John Commissiong
Owner
Company overview
| Headquarters | 675 Almanor Ave, The Parkinson's Institute, Sunnyvale, CA 94085, US |
| Website | |
| Keywords | Drug Discovery |
| Founded | 2008 |
| Employees | 1-10 |
About CNS Protein Therapeutics
CNS Protein Therapeutics ("CNS-PT") is privately-held biotechnology company developing novel growth factors for the treatment of human diseases. Our lead candidate CNS001 represents a new generation of growth factors characterized by its ability to correct protein misfolding. CNS001 is indicated for Parkinson's Disease and Ischemic Heart Disease.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Founder/Owner
Funding Data
CNS Protein Therapeutics has never raised funding before.
Belgium
United Kingdom
Spain
Italy
Frequently asked questions
CNS Protein Therapeutics is located in Sunnyvale, California, US.
CNS Protein Therapeutics generates an estimated annual revenue of $256,665. This revenue figure reflects the company's market position and business performance in its industry.
CNS Protein Therapeutics has an estimated valuation of $821,328. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.
CNS Protein Therapeutics was founded in 2008, making it 18 years old. The company has established itself as a significant player in its industry over this time.
CNS Protein Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
4.8
40,000 users
